A clinical trial update dated November 6, 2026 reports that the study titled "Development and Evaluation of the Support Intervention for Head and Neck Cancer Patients" has reached COMPLETED status. The trial, registered as NCT06674499, is listed without a specified phase (NA). Corticotropin, an approved compound, is associated with this trial record. The update reflects only the trial's status change and does not include any reported results or outcomes. No efficacy or safety findings were provided in this event data. The trial's completion status indicates that the study activities have concluded as of the date listed, but specific data from the study was not disclosed in this update. Readers should note that this brief reflects only the status and identifying details supplied in the trial record, not interpretive conclusions. Further details on study design, enrollment, or endpoints were not included in the available information. For additional context on corticotropin, including its approved uses and background, readers can consult the compound overview.
Corticotropin Trial NCT06674499 Marked Completed as of Nov 2026
See the full corticotropin overview
Source: https://clinicaltrials.gov/study/NCT06674499